[{"AccountsPayableCurrent_0_Q3_USD":6439000.0,"OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCreditLossesOnDebtSecuritiesHeld_0_Q3_USD":0.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":4082000.0,"OtherNonoperatingIncomeExpense_1_Q3_USD":11315000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q3_USD":13000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_3_Q3_USD":-143000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_1_Q3_USD":13000.0,"OtherAssetsNoncurrent_0_Q3_USD":9000.0,"OtherAccruedLiabilitiesCurrent_0_Q3_USD":10798000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q3_pure":0.084,"OperatingLeaseRightOfUseAsset_0_Q3_USD":64970000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":104360000.0,"OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale_1_Q3_USD":0.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":4697000.0,"OperatingLeaseCost_3_Q3_USD":11737000.0,"OperatingLeaseCost_1_Q3_USD":4067000.0,"OperatingIncomeLoss_3_Q3_USD":-147612000.0,"OperatingIncomeLoss_1_Q3_USD":-54623000.0,"OperatingExpenses_3_Q3_USD":186389000.0,"OperatingExpenses_1_Q3_USD":68848000.0,"NetIncomeLoss_3_Q3_USD":-143530000.0,"NetIncomeLoss_1_Q3_USD":-43308000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-92577000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-395301000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":449711000.0,"OperatingLeaseLiability_0_Q3_USD":109057000.0,"OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale_3_Q3_USD":0.0,"PaymentsToAcquireInvestments_3_Q3_USD":794712000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":32335000.0,"VariableLeaseCost_3_Q3_USD":1120000.0,"VariableLeaseCost_1_Q3_USD":529000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q3_USD":8016000.0,"StockholdersEquity_0_Q3_USD":730332000.0,"ShortTermLeaseCost_3_Q3_USD":0.0,"ShortTermLeaseCost_1_Q3_USD":0.0,"SharePrice_0_Q3_USD":59.27,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_3_Q3_USD":1546000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":38777000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":14225000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-700462000.0,"RestrictedCashNoncurrent_0_Q3_USD":15227000.0,"RestrictedCashAndCashEquivalentsNoncurrent_0_Q3_USD":15227000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":146004000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":53130000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":74617000.0,"ProfitLoss_3_Q3_USD":-143530000.0,"ProceedsFromStockOptionsExercised_3_Q3_USD":17265000.0,"ProceedsFromSaleMaturityAndCollectionsOfInvestments_3_Q3_USD":431746000.0,"ProceedsFromIssuanceOfPrivatePlacement_3_Q3_USD":0.0,"ProceedsFromIssuanceOfCommonStock_3_Q3_USD":411766000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":7701000.0,"PreferredStockValue_0_Q3_USD":3000.0,"PreferredStockSharesAuthorized_0_Q3_shares":5000000.0,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.001,"LongTermInvestments_0_Q3_USD":124877000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":95409201.0,"LiabilitiesCurrent_0_Q3_USD":91884000.0,"LettersOfCreditOutstandingAmount_0_Q3_USD":15200000.0,"CommonStockValue_0_Q3_USD":95000.0,"CommonStockSharesOutstanding_0_Q3_shares":95361312.0,"CommonStockSharesIssued_0_Q3_shares":95361312.0,"CommonStockSharesAuthorized_0_Q3_shares":250000000.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.001,"CommitmentsAndContingencies_0_Q3_USD":null,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":-38167000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q3_USD":144407000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":129180000.0,"CapitalizedContractCostAmortization_3_Q3_USD":2708000.0,"CapitalExpendituresIncurredButNotYetPaid_3_Q3_USD":3622000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_1_Q3_USD":-43295000.0,"AssetsCurrent_0_Q3_USD":693713000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":23900000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q3_shares":23900000.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":39770000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":13540000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":13540000.0,"AdditionalPaidInCapital_0_Q3_USD":1430769000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":-73000.0,"AccruedSalariesCurrent_0_Q3_USD":12200000.0,"AccruedLiabilitiesCurrent_0_Q3_USD":54003000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_3_Q3_USD":-3995000.0,"AccountsReceivableNetCurrent_0_Q3_USD":7311000.0,"Assets_0_Q3_USD":984571000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_3_Q3_USD":-143673000.0,"ContractWithCustomerAssetNetNoncurrent_0_Q3_USD":11158000.0,"ContractWithCustomerLiabilityCurrent_0_Q3_USD":23545000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q3_USD":78510000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q3_USD":3662000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q3_USD":12988000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q3_USD":13378000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q3_USD":13779000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFive_0_Q3_USD":14193000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q3_USD":13313000.0,"LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_0_Q3_USD":116254000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q3_USD":187567000.0,"InvestmentIncomeInterest_3_Q3_USD":1012000.0,"InvestmentIncomeInterest_1_Q3_USD":289000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":1921000.0,"IncreaseDecreaseInContractWithCustomerLiability_3_Q3_USD":-11057000.0,"IncreaseDecreaseInAccountsReceivable_3_Q3_USD":1795000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_3_Q3_USD":16287000.0,"GeneralAndAdministrativeExpense_3_Q3_USD":40385000.0,"GeneralAndAdministrativeExpense_1_Q3_USD":15718000.0,"FairValueAssetsLevel2ToLevel1TransfersAmount_0_Q3_USD":0.0,"FairValueAssetsLevel1ToLevel2TransfersAmount_0_Q3_USD":0.0,"EarningsPerShareBasicAndDiluted_3_Q3_USD":-1.52,"EarningsPerShareBasicAndDiluted_1_Q3_USD":-0.45,"DepreciationDepletionAndAmortization_3_Q3_USD":3644000.0,"DebtSecuritiesAvailableForSaleRealizedGainLoss_3_Q3_USD":0.0,"DebtSecuritiesAvailableForSaleRealizedGainLoss_1_Q3_USD":0.0,"ContractWithCustomerLiabilityNoncurrent_0_Q3_USD":32563000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":984571000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_Q3_shares":94396485.0,"Ticker":"FATE","CIK":"1434316","name":"FATE THERAPEUTICS INC","OfficialName":"Fate Therapeutics Inc. Common Stock","form":"10-Q","period":"20210930","fy":"2021.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"3545646272.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20211104"}]